INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,973 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
30
HJ
Holstein JensDirector
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$299K
7,049 sh
Nov 20, 2025Nov 21, 2025
Page 520 of 550
← PrevNext →
traded Nov 20, 2025
+1d
SEC Form 4

Evidence

30
DV
Date Rajeev VDirector
CRCLCircle Internet Group, Inc.
Open-market sale
SELL$354K
5,000 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

29
SJ
Slattery Paul JosephGENERAL COUNSEL & SECRETARY
BSLKBolt Projects Holdings, Inc.
Open-market sale
SELL$1,360
819 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

29
SE
Sachetta EricDirector
SRTSSensus Healthcare, Inc.
Open-market purchase
BUY$28K
7,000 sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$545K
7,220 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

29
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$530K
7,203 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

28
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$241K
10.3K sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

28
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$977K
25.5K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

28
EA
Eltoukhy AdamSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$96K
2,720 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

28
EA
Eltoukhy AdamSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$53K
1,447 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

27
PA
Pinto ArunChief Risk Officer
SOFISoFi Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$1.14M
46.1K sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

27
HJ
Holstein JensDirector
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$63K
1,460 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$222K
2,912 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$96K
2,470 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

25
EA
Eltoukhy AdamSEE REMARKS
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$22K
600 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$179K
4,599 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

25
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$106K
2,770 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

24
YE
Young William ERetired Director
SMBCSOUTHERN MISSOURI BANCORP, INC.
Open-market sale
SELL$81K
1,500 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

24
GM
Gloria MelanieChief Operating Officer
IMVTImmunovant, Inc.
Open-market sale
SELL$57K
2,375 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

23
HJ
Holstein JensDirector
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$61K
1,491 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

23
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
197 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

22
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$8,978
230 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Open-market sale · 10b5-1 plan
SELL$342K
9,701 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

21
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$268K
12.0K sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
LW
Lloyd George W.EVP, Investments & CLO
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$181K
4,628 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

21
HR
Horn David R.PRESIDENT & CFO
SEERSeer, Inc.
Open-market sale
SELL$13K
6,797 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

16
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$44K
1,561 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

16
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
989 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

16
KK
Keough KelliEVP, GBUL, SIPS
SOFISoFi Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$273K
10.3K sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

16
BS
Baig SaqibChief Accounting Officer
PTONPELOTON INTERACTIVE, INC.
Open-market sale · 10b5-1 plan
SELL$17K
2,387 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

15
SA
Shafer AndrewChief Cust Mkt & Brnd Officer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$9,937
5,000 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

15
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
492 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

14
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
2,075 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

11
MJ
McLay Kathryn J.Executive Vice President
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$407K
4,000 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

10
BJ
Blow Marla JDirector
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$3,086
58 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

10
BJ
Blow Marla JDirector
ETSYETSY INC
Open-market sale · 10b5-1 plan
SELL$13K
242 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence

8
BP
Badjate PramodPresident & GM, NFB
NTGRNETGEAR, INC.
Open-market sale · 10b5-1 plan
SELL$98K
4,000 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

5
GT
Glickman ToddSr. V.P., CFO & Treasurer
NVTSNavitas Semiconductor Corp
Open-market sale · 10b5-1 plan
SELL$2,556
345 sh
Nov 21, 2025Nov 21, 2025
traded Nov 21, 2025
+0dSEC Form 4

Evidence

4
VA
Viggiano AidanChief Financial Officer
TWLOTWILIO INC
Open-market sale · 10b5-1 plan
SELL$66K
546 sh
Nov 19, 2025Nov 21, 2025
traded Nov 19, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
2,500 sh
Nov 20, 2025Nov 21, 2025
traded Nov 20, 2025
+1dSEC Form 4

Evidence